Navigation Links
PROLOR Biotech to Present at the UBS 2009 Global Life Sciences Conference
Date:9/16/2009

ts regarding the results of current clinical studies and preclinical experiments and the effectiveness of PROLOR's long-acting protein programs, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that forward-looking statements involve risks and uncertainties that may affect PROLOR's business and prospects, including the risks that PROLOR may not succeed in developing any commercial products, including any long-acting versions of human growth hormone, erythropoietin, interferon beta, GLP-1, and other products; that the long-acting products in development may fail, may not achieve the expected results or effectiveness and/or may not generate data that would support the approval or marketing of these products for the indications being studied or for other indications; that ongoing studies may not continue to show substantial or any activity; that the actual dollar amount of any grants from the OCS is uncertain and is subject to policy changes of the Israeli government, and that such grants may be insufficient to assist with product development; and other risks and uncertainties that may cause results to differ materially from those set forth in the forward-looking statements. The development of any products using the CTP platform technology could also be affected by a number of other factors, including unexpected safety, efficacy or manufacturing issues, additional time requirements for data analyses and decision making, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing and the impact of patents and other proprietary rights held by competitors and other third parties. In addition to the risk factors described above, investors should consider the economic, competitive, governmental, technological and other factors discussed in PROLOR's filings with the Securities and Exchange Commission.

    PROLOR CONTACT:     
'/>"/>
SOURCE PROLOR Biotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PROLOR Biotech Acquires License Option from Yeda for Development of Long-Acting Anti-Obesity Drug
2. PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
3. PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin
4. Strong Social Connections Needed for Biotech to Grow in Los Angeles
5. Micromet to Present at the 16th Annual NewsMakers in the Biotech Industry Conference on September 16, 2009
6. Ganeden Biotech Introduces the First Probiotic Thin Strip
7. Champions Biotechnology Reports Fiscal 2010 First Quarter Financial Results
8. China Agro-Technology Holdings Announces Launch of Agricultural Biotech Website
9. BioSpecifics Technologies Corp. To Present at BioCentury NewsMakers in the Biotech Industry Conference
10. ThromboGenics is Shortlisted for "Biotech Company of the Year" and "Licensing Deal of the Year" at Scrip Awards 2009
11. Centocor Ortho Biotech Receives FDA Complete Response Letter Regarding DOXIL(R) for the Treatment of Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... (HZDR), the Vienna University of Technology and the ... nearly perfect semiconductor crystals into a silicon nanowire. ... very fast and multi-functional processing units can be ... The research results will be published in the ... considered the cornerstone of future chip technology, but ...
(Date:7/23/2014)... Last year, Formedix celebrated its partnership ... of data management solutions for clinical trials. The company ... electronic data capture (EDC) and clinical data management. Formedix, ... tools added TrialMaster to its Transform for EDC product ... for TrialMaster, is being released this week, in response ...
(Date:7/23/2014)... July 23, 2014 ... of Trendlines Agtech , announced it has ... Israel,s leading agricultural thermoplastics applications companies. ... Valentis,s technology combines nanocrystalline cellulose (NCC), a biodegradable, ... additional nanoparticles to produce highly improved polymeric films. ...
(Date:7/23/2014)... July 23, 2014 Shire ... the global specialty biopharmaceutical company, and ArmaGen, a ... worldwide licensing and collaboration agreement for AGT-182, an ... treatment of both the central nervous system (CNS) ... (MPS II). This collaboration strengthens Shire,s rare disease ...
Breaking Biology Technology:A crystal wedding in the nanocosmos 2Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 2Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 3Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 2Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 4Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 5
... Harry Whelan has become the first Medical College ... Defense University in Washington, D.C. , ,Whelan, a professor of ... signed a two-year contract at the Center for Technology ... around the country receiving the appointment, he will be spending ...
... Institute predicts moderate Wisconsin biopharmaceutical growth ... Third Wave appoints regulatory director , ... ,Wisconsin is home to significant biopharmaceutical innovation but ... a recent report prepared by the Milken ...
... group of Midwest technology consultants and you want to get them talking, ... free? Its an amazing thing. , ,You can ply your trade inside ... and all you have to do is hang out a shingle. All ... you to perform your services for no money. , ,When I used ...
Cached Biology Technology:Medical College of Wisconsin researcher gets national defense appointment 2Tech Digest: whats moving in the Midwest 2Dont work for free on a maybe someday 2Dont work for free on a maybe someday 3Dont work for free on a maybe someday 4
(Date:7/23/2014)... is available in German . ... to cells, drive metabolic processes and transmit signals. To ... shapes. Scientists at the Max Planck Institute for Developmental ... be constructed of similar amino acid chains even when ... proteins that exist today arose from common precursors. Presumably, ...
(Date:7/23/2014)... BioCatch, the global leader in cognitive biometric ... named in Gartner,s Market Guide for Online Fraud Detection ... Quadrant for Web Fraud Detection. In the ... to deliver passive biometric analysis and predicted, "By 2017, ... at least 30% of one-stop fraud detection solutions - ...
(Date:7/23/2014)... for clinical use of induced pluripotent stem cell ... been hindered by the risk of dysregulated cell ... to use etoposide treatment to halt teratoma formation ... specifically acute myocardial infarction, is demonstrated in an ... a peer-reviewed journal from Mary Ann Liebert, Inc., ...
Breaking Biology News(10 mins):Protein evolution follows a modular principle 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 3
... latest-generation DNA sequencing technology to become the first explorers ... "This project is one of the first attempts to ... than a single organism," says Nicole Gerardo, assistant professor ... we can understand how these ants have evolved to ...
... the Centers for Disease Control and Prevention (CDC) found ... by age of menarche and total number of lifetime ... over the course of a woman,s lifetime may influence ... this study are published in Cancer Epidemiology, Biomarkers ...
... We see the face of the Virgin Mary staring up ... portion of our meal for $37,000 on eBay. We believe in ... science offers a wealth of rational explanations for natural phenomena, we ... And we,ll even go to war to protect our delusions against ...
Cached Biology News:Landmark project to map genomics of complex ant systems 22 reproductive factors are important predictors of death from ovarian cancer 22 reproductive factors are important predictors of death from ovarian cancer 3Our 'caveman logic' embraces ESP over evolution 2
Umbilical cord blood CD4+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
Human endothelial progenitor cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
Human monocyte-derived dendritic cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
...
Biology Products: